860 related articles for article (PubMed ID: 30678377)
21. Phages Needed against Resistant Bacteria.
Moelling K
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
[TBL] [Abstract][Full Text] [Related]
22. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
[TBL] [Abstract][Full Text] [Related]
23. Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.
Donovan DM
Recent Pat Biotechnol; 2007; 1(2):113-22. PubMed ID: 19075835
[TBL] [Abstract][Full Text] [Related]
24. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment.
Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z
J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831
[TBL] [Abstract][Full Text] [Related]
25. Phage Therapy: The Pharmacology of Antibacterial Viruses.
Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
[TBL] [Abstract][Full Text] [Related]
26. [Bacteriophages in the battle against multidrug resistant bacteria].
van der Meer JWM; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
[TBL] [Abstract][Full Text] [Related]
27. Phage Lytic Enzymes.
Briers Y
Viruses; 2019 Jan; 11(2):. PubMed ID: 30699900
[TBL] [Abstract][Full Text] [Related]
28. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.
Lewis JM; Williams J; Sagona AP
Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972
[TBL] [Abstract][Full Text] [Related]
29. Phage cocktails and the future of phage therapy.
Chan BK; Abedon ST; Loc-Carrillo C
Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
[TBL] [Abstract][Full Text] [Related]
30. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
31. Implications of lytic phage infections inducing persistence.
Sanchez-Torres V; Kirigo J; Wood TK
Curr Opin Microbiol; 2024 Jun; 79():102482. PubMed ID: 38714140
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of phage-mediated biocontrol of bacteria.
Abedon ST
Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
[TBL] [Abstract][Full Text] [Related]
33. Characterization of
Moses S; Vagima Y; Tidhar A; Aftalion M; Mamroud E; Rotem S; Steinberger-Levy I
Viruses; 2021 Jan; 13(1):. PubMed ID: 33440682
[TBL] [Abstract][Full Text] [Related]
34. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
Segall AM; Roach DR; Strathdee SA
Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial bioagents based on principles of bacteriophage biology: an overview.
Knoll BM; Mylonakis E
Clin Infect Dis; 2014 Feb; 58(4):528-34. PubMed ID: 24270166
[TBL] [Abstract][Full Text] [Related]
36. Phage and phage cocktails formulations.
Mani I
Prog Mol Biol Transl Sci; 2023; 200():159-169. PubMed ID: 37739554
[TBL] [Abstract][Full Text] [Related]
37. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
[TBL] [Abstract][Full Text] [Related]
38. European regulatory aspects of phage therapy: magistral phage preparations.
Verbeken G; Pirnay JP
Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
[TBL] [Abstract][Full Text] [Related]
39. [Phage therapy, an alternative to antibiotic therapy?)].
Reina J; Reina N
Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
[TBL] [Abstract][Full Text] [Related]
40. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
